IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN
XXV
XXV was delisted on the 12th of April, 2018.
2 hedge funds and large institutions have $319K invested in IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
2,354% more capital invested
Capital invested by funds: $13K → $319K (+$306K)
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$316K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$13K |
XXV Hedge Fund Activity: Q4 2016 in Review
2 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN (XXV) for Q4 2016, worth a combined $319K — up 2,354% from $13K a quarter earlier.
Fund positioning in XXV was balanced in Q4 2016: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $316K. The largest seller was UBS Group, exiting entirely with an estimated $13K sold.
- 2 institutional investors held IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN (XXV) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $319K of IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN stock for Q4 2016, up 2,354% quarter-over-quarter.
- 1 fund opened new IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN positions in Q4 2016 and 1 closed out, a net change of 0 holders.
- The largest IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN buyer in Q4 2016 was Susquehanna International Group, an estimated $316K added.
- The largest IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN seller in Q4 2016 was UBS Group, an estimated $13K sold.
Based on aggregated 13F filings for Q4 2016.